| Primary |
| Depression |
66.7% |
| Vomiting |
33.3% |
|
| Sopor |
66.7% |
| Parkinsonism |
33.3% |
|
| Secondary |
| Dementia Alzheimer's Type |
20.4% |
| Depression |
17.6% |
| Product Used For Unknown Indication |
12.9% |
| Schizophrenia |
12.5% |
| Drug Use For Unknown Indication |
8.9% |
| Anxiety |
3.2% |
| Agitation |
3.1% |
| Delusion |
2.9% |
| Hypochondriasis |
2.8% |
| Psychiatric Symptom |
2.8% |
| Self Injurious Behaviour |
1.9% |
| Constipation |
1.8% |
| Acute Psychosis |
1.7% |
| Bipolar Disorder |
1.7% |
| Ill-defined Disorder |
1.2% |
| Bipolar I Disorder |
1.1% |
| Insomnia |
1.1% |
| Mania |
0.8% |
| Multiple Drug Overdose Intentional |
0.8% |
| Pneumonia |
0.8% |
|
| Somnolence |
16.9% |
| Pneumonia Aspiration |
11.3% |
| Neuroleptic Malignant Syndrome |
7.0% |
| Self Injurious Behaviour |
7.0% |
| Completed Suicide |
5.6% |
| Liver Disorder |
5.6% |
| Sopor |
5.6% |
| Substance Abuse |
5.6% |
| Treatment Noncompliance |
4.2% |
| Tremor |
4.2% |
| Weight Increased |
4.2% |
| Asthenia |
2.8% |
| Epilepsy |
2.8% |
| Long Qt Syndrome |
2.8% |
| Myocardial Infarction |
2.8% |
| Renal Impairment |
2.8% |
| Respiratory Acidosis |
2.8% |
| Sluggishness |
2.8% |
| Accidental Overdose |
1.4% |
| Atelectasis |
1.4% |
|
| Concomitant |
| Schizophrenia |
31.7% |
| Depression |
7.9% |
| Drug Use For Unknown Indication |
6.8% |
| Prophylaxis |
6.5% |
| Product Used For Unknown Indication |
5.1% |
| Psychotic Disorder |
4.6% |
| Insomnia |
4.3% |
| Acute Myocardial Infarction |
4.1% |
| Agitation |
3.5% |
| Constipation |
3.5% |
| Diabetes Mellitus |
3.0% |
| Bipolar Disorder |
2.2% |
| Bipolar I Disorder |
2.2% |
| Delusion |
2.2% |
| Hallucination, Auditory |
2.2% |
| Hypertension |
2.2% |
| Nasopharyngitis |
2.2% |
| Pneumonia |
2.2% |
| Central Nervous System Lymphoma |
1.9% |
| Dementia |
1.9% |
|
| Neuroleptic Malignant Syndrome |
9.0% |
| Ventricular Fibrillation |
9.0% |
| Hepatitis Cholestatic |
7.5% |
| Withdrawal Syndrome |
7.5% |
| Blood Lactate Dehydrogenase Increased |
6.0% |
| Disseminated Intravascular Coagulation |
6.0% |
| Melaena |
6.0% |
| Aspartate Aminotransferase Increased |
4.5% |
| Blood Creatine Phosphokinase Increased |
4.5% |
| Death |
4.5% |
| Rectal Haemorrhage |
4.5% |
| Somnolence |
4.5% |
| Stevens-johnson Syndrome |
4.5% |
| Tremor |
4.5% |
| Alopecia |
3.0% |
| Anxiety |
3.0% |
| Central Nervous System Inflammation |
3.0% |
| Colostomy |
3.0% |
| Eczema |
3.0% |
| Hypoglycaemia |
3.0% |
|
| Interacting |
| Schizophrenia |
51.6% |
| Constipation |
12.9% |
| Aggression |
6.5% |
| Insomnia |
6.5% |
| Pneumonia |
6.5% |
| Bipolar Disorder |
3.2% |
| Personality Disorder |
3.2% |
| Product Used For Unknown Indication |
3.2% |
| Psychotic Disorder |
3.2% |
| Attention Deficit/hyperactivity Disorder |
1.6% |
| Emotional Disorder |
1.6% |
|
| Serotonin Syndrome |
22.2% |
| Ileus Paralytic |
11.1% |
| Muscle Twitching |
11.1% |
| Neuroleptic Malignant Syndrome |
11.1% |
| Parkinsonism |
11.1% |
| Pyrexia |
11.1% |
| Rhabdomyolysis |
11.1% |
| Sepsis |
11.1% |
|
